secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2024-07-26T23:59:59+00:00
Accession:  0001013762-24-001604
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

60 Degrees Pharma awarded $311,862 U.S. Army contract for ARAKODA packaging validation
--------------------------------------------------------------------------------

- Awarded a fixed-price contract valued at $311,862 with U.S. Army Medical Materiel Development Activity for new bottle and replacement blister packaging of ARAKODA.
- Contract aims to facilitate commercial validation to ensure continued U.S. government procurement of malaria prevention drug ARAKODA.
- Q1 2024 ARAKODA net sales revenue increased 515% YoY to $105.7 thousand; company increased commercial batch size in Q1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000101376224001604/0001013762-24-001604-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000101376224001604/ea021010701-8k_60degrees.htm
  HTML page:      https://secwatch.observer/filing/0001013762-24-001604

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer